My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Second Sight Medical Products (EYES)
EYES nasdaq
United States
Second Sight Medical Products

Second Sight Medical Products Stock Analysis & Ratings

Second Sight Medical Products Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Second Sight Medical Products stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


EYES Stock Stats

Previous Close$1.98
Bid1.83 x 200
Ask1.85 x 100
Today’s Range$1.85 - $2.04
52-Week Range$0.99 - $20.00
Average Volume1.16M
Market Cap$72.91M
P/E Ratio-6.8
Earnings DateMar 10, 2022

Company Description

Second Sight Medical Products

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. Its product, the Argus II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.
Medical Devices & Instruments
Scott Dunbar
13170 Telfair Avenue, Sylmar, CA, 91342, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Second Sight Medical Products’s price range in the past 12 months?
Second Sight Medical Products lowest stock price was $0.99 and its highest was $20.00 in the past 12 months.
    What is Second Sight Medical Products’s market cap?
    Second Sight Medical Products’s market cap is $72.91M.
      What is Second Sight Medical Products’s price target?
      Currently, no data Available
      What do analysts say about Second Sight Medical Products?
      Not enough analysts have published a price target to provide an average price target.
      When is Second Sight Medical Products’s upcoming earnings report date?
      Second Sight Medical Products’s upcoming earnings report date is Mar 10, 2022 which is in 98 days.
        How were Second Sight Medical Products’s earnings last quarter?
        Second Sight Medical Products released its earnings results on Nov 04, 2021. The company reported -$0.064 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.064.
          Is Second Sight Medical Products overvalued?
          According to Wall Street analysts Second Sight Medical Products’s price is currently Overvalued.
            Does Second Sight Medical Products pay dividends?
            Second Sight Medical Products does not currently pay dividends.
            What is Second Sight Medical Products’s EPS estimate?
            Second Sight Medical Products’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Second Sight Medical Products have?
            Second Sight Medical Products has 39,410,000 shares outstanding.
              What happened to Second Sight Medical Products’s price movement after its last earnings report?
              Second Sight Medical Products reported an EPS of -$0.064 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.748%.
                Which hedge fund is a major shareholder of Second Sight Medical Products?
                Currently, no hedge funds are holding shares in EYES

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis